Advertisement
Screener

Alamar Biosciences, Inc. (ALMR) Payments of Stock Issuance Costs

Alamar Biosciences, Inc. Payments of Stock Issuance Costs

Alamar Biosciences, Inc. (ALMR) reported Payments of Stock Issuance Costs of $6.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-11

  • Alamar Biosciences, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $3.93M.
  • Alamar Biosciences, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $2.22M.
Period endPayments of Stock Issuance Costs 3 monthPayments of Stock Issuance Costs 6 month
2026-06-30$3.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$6.15M
10-Q · filed 2026-08-11
2026-03-31$2.22M
10-Q · filed 2026-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42